Today's biggest movers. Our screens cover mega-cap down to micro-cap and surface the catalyst behind the move.
Fair Isaac Corporation (FICO) rises sharply as investors react to a major mortgage credit-scoring policy change and heavy trading volume. The move comes after new loan-level pricing rules aligned Classic FICO and VantageScore 4.0, while analysts also reassessed the stock following a recent downgrade.
Corteva, Inc. (CTVA) crashes in after-hours trading after its October 1 separation of the seed business into Vylor. The move appears tied to the corporate action, not a fresh earnings miss, and investors should evaluate the combined value of CTVA and Vylor before drawing conclusions.
Vicor Corporation (VICR) climbs after hours after raising Q3 revenue guidance on stronger royalties from its Vertical Power Delivery technology. The move highlights growing AI infrastructure demand and a potentially expanding licensing stream, though the stock’s premium valuation means investors should watch for confirmation in regular trading.
Accenture plc (ACN) jumps after a stronger-than-expected fiscal fourth-quarter report. Revenue topped guidance, adjusted EPS beat estimates, and broad-based growth across regions and services eased concerns about enterprise spending and AI disruption.
Annaly Capital Management, Inc. (NLY) drops sharply, but the move is mainly tied to its $0.75 ex-dividend date rather than a fresh earnings miss or dividend cut. Heavy volume and a high yield amplified the decline, while investors now look ahead to the next earnings report for confirmation of operating strength.
Cerebras Systems Inc. (CBRS) drops after a report that Nvidia may power OpenAI’s Ultrafast tier, undercutting a key customer-validation narrative. The stock saw heavier-than-normal trading as investors weighed strong revenue growth and backlog against ongoing losses and competitive pressure.
Summit Therapeutics Inc. (SMMT) rises after AstraZeneca’s $2 billion strategic investment sparked heavy trading and renewed confidence in the company’s lead cancer drug, ivonescimab. The move highlights investor enthusiasm for the partnership, but the stock still carries biotech execution, clinical, and dilution risk.
Gen Digital Inc. (GEN) rises after management lifted its fiscal 2027 outlook and defended acquisitions as part of its growth strategy. The stock’s jump comes on heavier-than-normal volume, helping offset a steep one-month slide and signaling renewed investor interest in the cybersecurity name.
Snowflake Inc. (SNOW) rises after investors digest its $3.5 billion convertible note financing and fresh enterprise AI partnership news. The rebound follows an earlier selloff tied to dilution concerns, while the company’s earnings beat streak and expanding ecosystem help support the stock’s longer-term story.
Jabil Inc. (JBL) drops sharply after reporting strong fiscal Q4 2026 results and issuing fiscal 2027 guidance. Despite beating EPS and revenue estimates, investors appear focused on valuation and whether future growth can justify the premium. The selloff came on heavy volume, signaling a broad repricing.
United Therapeutics Corporation (UTHR) climbs sharply as investors react to a major accelerated share repurchase, solid earnings, and ongoing pipeline progress. Heavy trading volume suggests the market is repricing the stock around capital returns and future growth, even as analyst skepticism remains.
MongoDB, Inc. (MDB) rises after a sharp CEO departure sparked heavy trading and a rebound from recent losses. The company reaffirmed guidance and highlighted new AI-focused products, but investors are still weighing leadership risk against strong growth and a premium valuation.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime